VYGR EPS Estimates
Voyager Therapeutics, Inc.
$2.47
+$0.01(+0.41%)
45
Overall
60
Value
36
Tech
39
Quality
Market Cap
$151.58M
Volume
763.21K
52W Range
$2.42 - $5.55
Target Price
$15.38
VYGR EPS estimates: the consensus estimate for Voyager Therapeutics, Inc.'s current fiscal year is -$1.63 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VYGR EPS Estimates
- EPS estimate, current quarter
- $-0.41
- EPS estimate, next quarter
- $-0.34
- EPS estimate, current year
- $-1.63
- EPS estimate, next year
- $-1.15
- EPS growth, 3-year
- -19.02%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.04 |
| 2024 | $-1.13 |
| 2023 | $3.08 |
| 2022 | $-1.21 |
| 2021 | $-1.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VYGR | $2.47 | +0.4% | 763.21K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Voyager Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW